Related Experiment Video
Updated: Apr 26, 2026

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Agreement between public register and adjudication committee outcome in a cardiovascular randomized clinical trial
Erik Kjøller1, Jørgen Hilden2, Per Winkel3
1Department of Cardiology, Herlev Hospital, Copenhagen University Hospital and The Copenhagen Trial Unit, Center for Clinical Intervention Research, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Insights
Outcomes from public health registers show modest agreement with committee assessments in clinical trials. However, the intervention effects estimated from register data closely matched those from committee evaluations, suggesting registers may replace committees.
Area of Science:
- Clinical trial methodology
- Health informatics
- Biostatistics
Background:
- Randomized controlled trials (RCTs) often rely on expert committees for outcome adjudication.
- Public health registers offer a potential alternative data source for outcome assessment.
Purpose of the Study:
- To compare the agreement between committee-assessed outcomes and outcomes identified from public registers in the CLARICOR trial.
- To evaluate if public registers can reliably estimate intervention effects.
Main Methods:
- The CLARICOR trial data (n=4,372) was used, comparing committee adjudication with outcomes derived from International Classification of Diseases codes in public registers.
- Agreement was calculated by cross-tabulating diagnoses and comparing intervention effect estimates (hazard ratios).
Main Results:
- Overall agreement was 74% for hospital discharges and 60% for causes of death between the two methods.
- The intervention effect estimated using public register data was within 4% of the original committee-assessed value.
Conclusions:
- A modest agreement exists between formal adjudication and outcomes from public registers.
- Public registers provide comparable intervention effect estimates, suggesting they could potentially replace adjudication committees in RCTs.
Unlabelled:
The objective of this study is to describe the agreement between randomized trial outcome assessment by committee and outcomes entirely identified through public registers.
Methods:
In the CLARICOR trial, 4,372 patients with stable coronary heart disease received a short course of clarithromycin versus placebo and were followed up for 2.6 years. The pertinent hospital records and death certificates had originally been evaluated by the adjudication committee using common definitions of outcomes mapped into a 6-category list. We now mechanically converted the International Classification of Diseases-coded diagnoses of the public registries into the same categories. After cross-tabulation of the committee diagnoses with National Patient Register diagnoses and Register of Causes of Death, we calculate agreement and compare the estimated intervention effects of the 2 data sets.
Results:
With public register data, the protocol-specified categories were slightly more frequent. Overall agreement was 74% for hospital discharges and 60% for cause of death, but the intervention effect, expressed as a hazard ratio, stayed within 4% of the value originally obtained with the adjudication committee (P ≥ .35).
Conclusions:
Our results show a modest agreement between formal adjudication and outcomes deducible from public registers. However, the estimated intervention effect did not differ noticeably between the 2 data sources. If studies on a wide range of public registers confirm these findings, register outcomes may be considered as a replacement for adjudication committees.
Related Concept Videos
Cardiovascular Drugs: Classification based on Therapeutic Indications
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Acute Coronary Syndrome III: Diagnostic Studies
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Bioequivalence studies: Biowaivers

